References
- 1. Joint Programming Initiative on Antimicrobial Resistance -Strategic Research Agenda, available at: https://www.jpiamr.eu
- 2. World Economic Forum (2013). Global Risks 2013. Eighth Edition. - An initiative of the Risk. Response Network. Accessed on the 3rd of April 2013: http://www3.weforum.org/docs/WEF_GlobalRisks_Report_2013.pdf
- 3. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions. Clin Microbiol Rev. 2012;25:682-707.10.1128/CMR.05035-11
- 4. Forslund K, Sunagawa S, Kultima JR, et al. Country-specific antibiotic use practices impact the human gut resistome. Genome Res. 2013;23:1163-69.10.1101/gr.155465.113
- 5. Pallecchi L, Bartoloni A, Riccobono E, et al. Quinolone Resistance in Absence of Selective Pressure: The Experience of a Very Remote Community in the Amazon Forest. PLoS Negl Trop Dis. 2012:6: 1790. doi:10.1371/journal.pntd.0001790
- 6. Rugina S, Dumitru IM. The Role of infectious diseases specialist in critical patient assistance, J Crit Care Med. 2018;2(Suppl 1):24.
- 7. ECDC Surveillance Report. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012. Accessed on the 11th of April 2013: http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx?ID=1155
- 8. Rice LB. (2008). - Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;198:1079-81.
- 9. Grundmann H, Bärwolff S, Tami A, et al. How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med, 2005;33:946-51.10.1097/01.CCM.0000163223.26234.56
- 10. Silbergeld EK, Graham J, Price LB. Industrial Food Animal Production, Antimicrobial Resistance, and Human Health. Annu Rev Public Health. 2008;29:151-69.